1349PSubsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC in LUX-Lung (LL) 3, 6 and 7 L.V. Sequist,Y-L. Wu,Martin Schuler,T. Kato,J.C-H. Yang,Hiroshi Tanaka,Toyoaki Hida,Shun Lu, K. Park,Scott A. Laurie,Jaafar Bennouna,D. Moro Sibilot,Angela Märten,Barbara Peil, E. Ehrnrooth,Nobuyuki Yamamoto,Kazuhiko NakagawaAnnals of Oncology（2017）引用 10|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
